WUXI BIO (02269): Miao Jingwen appointed as non-executive director.

19:26 20/11/2024

Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).

WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.

New stock forecast | Increasing revenue without increasing profits highlights systemic dilemma, industry leader Goraylee is at a "crossroads"

Berkshire Hathaway (BRK.A.US) reported a fourth quarter operating profit of $10.2 billion, a year-on-year decrease of nearly 30%.

Sinolink: Rocket Lab (RKLB.US) Achieves Record High Performance in 2025 with a Backlog of Orders totaling $1.85 billion.

New stock forecast | Increasing revenue without increasing profits highlights systemic dilemma, industry leader Goraylee is at a "crossroads"

Berkshire Hathaway (BRK.A.US) reported a fourth quarter operating profit of $10.2 billion, a year-on-year decrease of nearly 30%.

Sinolink: Rocket Lab (RKLB.US) Achieves Record High Performance in 2025 with a Backlog of Orders totaling $1.85 billion.